Hu Jinfeng, Geng Meiyu, Li Jing, Xin Xianliang, Wang Jia, Tang Minke, Zhang Juntian, Zhang Xiao, Ding Jian
Department of Pharmacology, Marine Drug and Food Institute, Ocean University of China, Quingdao, China.
J Pharmacol Sci. 2004 Jun;95(2):248-55. doi: 10.1254/jphs.fpj04004x.
In this paper, we investigated interactions of the acidic oligosaccharide sugar chain (AOSC), derived from brown algae Echlonia kurome OKAM, with amyloid beta protein (Abeta). We observed that AOSC inhibited the toxicity induced by Abeta in both primarily cortical cells and the SH-SY5Y cell line. We also observed that AOSC inhibited the apoptosis induced by Abeta in SH-SY5Y by reducing the elevated level of intracellular calcium concentration (Ca(2+)) and suppressing the generation of reactive oxygen species. Surface plasmon resonance analysis demonstrated that AOSC had affinity for both freshly-dissolved Abeta and 48-h incubated Abeta. Furthermore, AOSC blocked the fibril formation of Abeta, which may be responsible for its anti-cytotoxic effects. Thus, our results indicate that AOSC might be a potentially therapeutic compound for Alzheimer's disease.
在本文中,我们研究了源自褐藻冈村枝管藻的酸性寡糖糖链(AOSC)与β-淀粉样蛋白(Aβ)之间的相互作用。我们观察到,AOSC在原代皮层细胞和SH-SY5Y细胞系中均能抑制Aβ诱导的毒性。我们还观察到,AOSC通过降低细胞内钙浓度([Ca(2+)]i)的升高水平并抑制活性氧的产生,从而抑制了SH-SY5Y细胞中Aβ诱导的细胞凋亡。表面等离子体共振分析表明,AOSC对新溶解的Aβ和孵育48小时的Aβ均具有亲和力。此外,AOSC阻断了Aβ的纤维形成,这可能是其抗细胞毒性作用的原因。因此,我们的结果表明,AOSC可能是一种潜在的治疗阿尔茨海默病的化合物。